ArticleProceedings of the National Academy of Sciences of the United States of America2006

The small-molecule VEGF receptor inhibitor pazopanib (GW786034B) targets both tumor and endothelial cells in multiple myeloma.

Klaus Podar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.